CareDx, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
CareDx (CNDA) PT, Estimates Cut at Piper Jaffray Post Q4
March 18, 2015 8:51 AM EDTPiper Jaffray analyst William R. Quirk lowered estimates and his price target on CareDx, Inc (NASDAQ: CDNA) to $8.00 (from $13.00) following Q4 results but maintained an Overweight rating.
Quirk commented, "CareDx reported 4Q14 revenue growth of 35.8% to $8.0M, above our ($6.7M) and consensus ($6.9M) expectations, although a... More
CareDx (CDNA) Tops Q4 EPS by 11c
March 17, 2015 4:13 PM EDTCareDx (NASDAQ: CDNA) reported Q4 EPS of $0.00, $0.11 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $7.96 million versus the consensus estimate of $6.86 million.
For earnings history and earnings-related data on CareDx (CDNA) click here.
... More